Please login to the form below

Not currently logged in
Email:
Password:

CE mark

This page shows the latest CE mark news and features for those working in and with pharma, biotech and healthcare.

Prix Galien opens for entries with new award

Prix Galien opens for entries with new award

Products granted a CE mark within a five-year qualifying period are eligible for entry.

Latest news

  • EMA starts firming up its stance on personalised medicines EMA starts firming up its stance on personalised medicines

    The new In Vitro Diagnostics Regulation “foresees cooperation”between the medicines regulator and its medical device counterparts “in the evaluation of new companion diagnostics to obtain the CE label”. ... diagnostic, and therefore it too will

  • Danish Medicines Agency urges caution on health app use Danish Medicines Agency urges caution on health app use

    To be classified as a medical device an app must be able to make a diagnosis or treat a patient, and also be CE marked, the Agency explained. ... If it makes sense to use an app in a specific situation, it is important that the doctor or patient makes

  • Sanofi to develop a mobile app for insulin patients Sanofi to develop a mobile app for insulin patients

    Voluntis focuses on ‘embedding connectivity in therapeutics and medical intelligence in software’and last year gained FDA clearance and the European CE mark for the new mobile app.

  • Surviving Brexit Surviving Brexit

    In the case of low-risk (class I devices) the manufacture may affix the CE mark following a self-certification procedure. ... Once a CE-mark is granted it allows the product to be sold freely throughout the EU.

  • Apps as medical devices - UK regulator updates its guidance Apps as medical devices - UK regulator updates its guidance

    In the UK, as in the rest of Europe, software and apps that are defined as medical devices must gain a CE mark (kitemark) in line with the EU medical device ... Unit. Other apps that also have a CE mark include OncoAssist and Airstrip's patient

More from news
Approximately 1 fully matching, plus 24 partially matching documents found.

Latest Intelligence

  • Deal Watch June 2016 Deal Watch June 2016

    In Europe Cerus expects to apply for a CE Mark for the Intercept RBC System in the second half of 2016.

  • Pharma deals during November 2012 Pharma deals during November 2012

    The V2 is one of 5 hypertension-treating devices with a CE mark and will compete with Medtronic's “ Symplicity” (acquired from Ardian for $800m) and Covidien's “ OneShot” (acquired from

More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Pegasus

At Pegasus, we specialise in helping deliver healthy messages through integrated communication programmes. In fact, inspiring healthy decisions is all...

Latest intelligence

Island
Pharma’s isolated islands of innovation
With service design and technology often failing the patient, why perspective on improving outcomes need to change...
Uncertainty, austerity and Brexit
What does it mean for the life science sector?...
The Holy Grail of HCP Access
This is the data you need to gain access....

Infographics